KLG Stock +78.58% In 3 Months Since We Picked KLG Stock +78.58% In 3 Months Since We Picked Unlock All Top Buy Picks

Range Low Price High Price Comment
30 days $2.90 $4.87 Friday, 27th Jan 2023 CLBS stock ended at $3.55. This is 1.14% more than the trading day before Thursday, 26th Jan 2023. During the day the stock fluctuated 1.43% from a day low at $3.50 to a day high of $3.55.
90 days $2.90 $4.87
52 weeks $0.402 $9.75

Historical Caladrius Biosciences prices

Date Open High Low Close Volume
Feb 05, 2020 $2.83 $2.86 $2.77 $2.83 7 752
Feb 04, 2020 $2.91 $3.00 $2.70 $2.81 72 750
Feb 03, 2020 $2.87 $3.02 $2.87 $2.95 12 425
Jan 31, 2020 $2.98 $3.03 $2.90 $2.91 21 180
Jan 30, 2020 $2.99 $3.03 $2.98 $2.98 4 530
Jan 29, 2020 $2.92 $3.04 $2.92 $3.01 44 879
Jan 28, 2020 $2.90 $3.03 $2.90 $3.01 5 333
Jan 27, 2020 $3.04 $3.04 $2.91 $2.91 14 621
Jan 24, 2020 $3.05 $3.09 $2.92 $3.04 23 974
Jan 23, 2020 $2.91 $3.04 $2.91 $3.04 3 045
Jan 22, 2020 $2.98 $3.00 $2.91 $2.97 18 267
Jan 21, 2020 $3.05 $3.10 $2.88 $3.04 44 089
Jan 17, 2020 $3.17 $3.21 $3.11 $3.11 15 257
Jan 16, 2020 $3.26 $3.35 $3.20 $3.24 10 393
Jan 15, 2020 $3.37 $3.48 $3.17 $3.34 19 868
Jan 14, 2020 $3.40 $3.56 $3.22 $3.38 22 567
Jan 13, 2020 $3.58 $3.64 $3.07 $3.28 91 755
Jan 10, 2020 $2.95 $3.47 $2.93 $3.47 174 929
Jan 09, 2020 $2.77 $2.96 $2.77 $2.96 17 513
Jan 08, 2020 $2.76 $2.93 $2.76 $2.83 12 583
Jan 07, 2020 $2.75 $2.83 $2.71 $2.81 13 008
Jan 06, 2020 $2.80 $2.92 $2.68 $2.84 76 839
Jan 03, 2020 $2.53 $2.85 $2.49 $2.80 81 135
Jan 02, 2020 $2.47 $2.55 $2.41 $2.52 13 733
Dec 31, 2019 $2.51 $2.55 $2.42 $2.51 27 631
Click to get the best stock tips daily for free!

About Caladrius Biosciences

Caladrius Biosciences Caladrius Biosciences, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing cellular therapies to reverse disease and/or promote the regeneration of damaged tissue. Its product candidates include HONEDRA, a recipient of SAKIGAKE designation that is in Phase II clinical trial for the treatment of critical limb ischemia; XOWNA that is in Phase IIb clinical trial for the treatment of coronary microvascular dysf... CLBS Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT